Trial Profile
Efficacy of Tiotropium bromide (Spiriva 2.5 microgram Respimat 60 puffs) for chronic asthmatic cough refractory to intensive therapies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2020
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Theophylline
- Indications Asthma
- Focus Therapeutic Use
- 09 Jul 2020 Status changed from recruiting to completed.
- 13 Sep 2016 Status changed from not yet recruiting to recruiting.
- 31 May 2016 New trial record